The Mumbai-based company said the approval was part of India`s accelerated approval process and the drug was meant for "restricted emergency use," meaning patients must sign their consent before being treated by the drug.
https://ift.tt/eA8V8J from https://ift.tt/2Cqz0qr
ليست هناك تعليقات:
إرسال تعليق